You are here

Healthcare Economics & Policy

 

The global ultrasound market is poised for a strong 2018 due in part to the expanded use of the imaging modality across medical specialties, along with projected growth in most major markets. Findings were published by Signify Research, an independent supplier of market intelligence to the global healthcare technology industry.

CMS announced a change in its payment policy to make it easier for patients with implantable cardiac devices to receive reimbursement for MRI scans.

Brent Shafer, previously CEO of Philips North America, has been named Cerner's new chief executive and chairman effective Feb. 1.

Today, the Medical Imaging and Technology Alliance (MITA) sent a letter to members of Congress, urging them to repeal the medical device tax prior to Jan. 29, the date medical device companies are required to resume payments after a two-year suspension.

The U.S. Food and Drug Administration (FDA) has officially announced the availability of newly drafted guidelines that ease the process of regulating medical devices while maintaining the statutory requirements for safety clearance, according to a news release.

 

Recent Headlines

ACR preliminarily pleased with 2017 physician fee schedule

Last Thursday, CMS proposed changes in the Medicare Physician Fee Schedule (MPFS). The American College of Radiology quickly said it would be reviewing the details in the coming weeks and—in advance of that activity as well as of the September 6 comment deadline—noted its overall approval of the proposed rule as released. 

Royal Philips acquires PathXL, hopes to boost digital pathology industry

Dutch healthcare technology company Royal Philips bought the Northern Irish pathology image analysis firm PathXL, Royal Philips announced June 21.

 
Teaching hospital documents the pros and cons of going to overnight attending rad coverage

In 2013 Boston Medical Center, a 496-bed teaching hospital affiliated with Boston University, bit the bullet and rolled out 24/7 in-house attending radiology with an eye on improving patient care. The bitten bullet ended up carrying an annual price tag of $850,000. Have the returns been worth the investment?

Millennial rad residents learn healthcare economics better with apps

Recent survey data revealed that most radiology residents cannot estimate imaging costs within 50 percent of accepted Medicare fees. Armed with this eyebrow-raising insight, researchers from Harvard and Brown Universities have studied the use of iPad apps for teaching tech-savvy millennials the basics of healthcare economics. Their conclusion: The approach works. 

Decision support probably isn’t to blame for much ‘imaging leakage’

It’s understandable that hospital systems might balk before setting up ordering providers with order-entry clinical decision support (CDS) tools that, in theory, stand to drive imaging referrals outside the system. After all, referrers have been known to get around CDS recommendations they don’t like by simply sending patients elsewhere. 

Brain science acts to manage a scientist surplus while averting a brain drain

It’s a good problem to have, but it’s still a problem: There are more PhD students training for careers in neuroscience research than academic institutions can possibly employ. 

NBA partners with GE Healthcare on $1.5 million in injury research funding

With the NBA Playoffs in full swing, the league is also working to fund research focused on protecting players from injury.

PCORI earmarks more than $40 million for patient-centered research projects

The Patient-Centered Outcomes Research Institute (PCORI) has announced $44.4 million in funding for 21 new clinical effectiveness research studies centered around patient care, according to a press release.

FDA gives clearance for FUJIFILM VisualSonics ultra-high frequency ultrasound system

FUJIFILM VisualSonics Inc., a subsidiary of FUJIFILM SonoSite, has announced that its Vevo MD ultra-high frequency clinical ultrasound system has received 510(k) clearance from the FDA.

Philips' low-dose CT suite cleared by FDA for lung cancer screening

Philips announced today that its suite of CT solutions has received 501(k) clearance from the FDA for low-dose lung cancer screening.

Pages